Evidence map›Paper›PMID 23661673›Full record

ArticleCirculation. Cardiovascular genetics2013

Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.

Mauro W Costa, Guanglan Guo, Orit Wolstein, Molly Vale, Maria L Castro, Libin Wang, Robyn Otway, Peter Riek, Natalie Cochrane, Milena Furtado and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation. Cardiovascular genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 88 citations in OpenAlex.

  1. NovelHeartRhythm case reports · 2026
    Article
  2. Article
  3. Review
  4. Discovery ofDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Application of 4-D ultrasound-derived regional strain and proteomics analysis inAmerican journal of physiology. Heart and circulatory physiology · 2023
    Article
  9. Review
  10. Identification ofDiagnostics (Basel, Switzerland) · 2023
    Article
  11. Review
  12. Article
  13. A heterozygous p.S143P mutation inFrontiers in cell and developmental biology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

Mauro W CostaDevelopmental and Stem Cell Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. mauro.dacosta@monash.edu
Guanglan Guo
Orit Wolstein
Molly Vale
Maria L Castro
Libin Wang
Robyn Otway
Peter Riek
Natalie Cochrane
Milena Furtado
Christopher Semsarian
Robert G Weintraub
Thomas Yeoh
Christopher Hayward
Anne Keogh
Peter Macdonald
Michael Feneley
Robert M Graham
Jonathan G Seidman
Christine E Seidman
Nadia Rosenthal
Diane Fatkin
Richard P Harvey
Murdoch Children's Research Institute · AUAustralian Regenerative Medicine Institute · AURoyal Children's Hospital · AUSt Vincent's Hospital Sydney · AUHarvard University · USRoyal Prince Alfred Hospital · AUUniversity of Sydney · AUCentenary Institute · AUMonash University · AU

Funding

Mapping Transcriptional Networks in Cardiac DevelopmentU01HL098166 · NHLBI · HARVARD MEDICAL SCHOOL · PI SEIDMAN, JONATHAN G · 2009 to 2014
$9.5M
Howard Hughes Medical InstituteNHLBI NIH HHS U01 HL098166
6 · The paper itself

Abstract

backgroundThe transcription factor NKX2-5 is crucial for heart development, and mutations in this gene have been implicated in diverse congenital heart diseases and conduction defects in mouse models and humans. Whether NKX2-5 mutations have a role in adult-onset heart disease is unknown. METHODS AND

resultsMutation screening was performed in 220 probands with adult-onset dilated cardiomyopathy. Six NKX2-5 coding sequence variants were identified, including 3 nonsynonymous variants. A novel heterozygous mutation, I184M, located within the NKX2-5 homeodomain, was identified in 1 family. A subset of family members had congenital heart disease, but there was an unexpectedly high prevalence of dilated cardiomyopathy. Functional analysis of I184M in vitro demonstrated a striking increase in protein expression when transfected into COS-7 cells or HL-1 cardiomyocytes because of reduced degradation by the Ubiquitin-proteasome system. In functional assays, DNA-binding activity of I184M was reduced, resulting in impaired activation of target genes despite increased expression levels of mutant protein.

conclusionsCertain NKX2-5 homeodomain mutations show abnormal protein degradation via the Ubiquitin-proteasome system and partially impaired transcriptional activity. We propose that this class of mutation can impair heart development and mature heart function and contribute to NKX2-5-related cardiomyopathies with graded severity.

Indexed as

AdolescentAdultAge of OnsetAmino Acid SequenceAnimalsBase SequenceCardiomyopathiesChlorocebus aethiopsCOS CellsFemaleHeart Defects, CongenitalHomeobox Protein Nkx-2.5Homeodomain ProteinsHumansMaleMiddle AgedHomeobox Protein Nkx-2.5Homeodomain ProteinsNKX2-5 protein, humanTranscription Factorsdilated cardiomyopathygene mutationsNKX2-5transcription factorsUBIQUITIN-proteasome system

Identifiers

PMID23661673
PMCPMC3816146
OpenAlexW2060835874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.